What is Abbott Laboratories worth?
With the base-case assumptions below, a discounted cash flow model on Abbott Laboratories's reported free cash flow gives $62.38 per share. The share price was $101.29 on September 25, 2026, 62% above that value.
Inputs from the filings
Three sets of assumptions
| Case | Growth yrs 1-5 | Discount rate | Value per share | Value vs price |
|---|---|---|---|---|
| Bear | 0.0% | 10.0% | $32.55 | -68% |
| Base | 5.0% | 9.0% | $62.38 | -38% |
| Bull | 10.0% | 8.0% | $118.08 | +17% |
Sensitivity: base case value per share
| 1.5% | 2.0% | 2.5% | 3.0% | 3.5% | |
|---|---|---|---|---|---|
| 7.0% | $83.73 | $90.22 | $98.16 | $108.09 | $120.85 |
| 8.0% | $67.81 | $72.03 | $77.00 | $82.98 | $90.28 |
| 9.0% | $56.18 | $59.06 | $62.38 | $66.26 | $70.84 |
| 10.0% | $47.31 | $49.35 | $51.68 | $54.33 | $57.39 |
| 11.0% | $40.33 | $41.83 | $43.51 | $45.39 | $47.53 |
Where the presets come from
Base: years 1 to 5 grow at Abbott Laboratories's revenue growth rate over the last 5 fiscal years (5.1% a year), held between -5% and 15%. Years 6 to 10 grow halfway between that and the long-run rate of 2.5%. Future cash is discounted at 9% a year.
Bear: 5 points less growth, 2% long-run growth, 10% discount rate. Bull: 5 points more growth (at most 25%), 3% long-run growth, 8% discount rate.
Value per share = (present value of 10 years of free cash flow + present value of everything after + cash - debt) / diluted shares.
This is a model run on assumptions, not a recommendation or a price target. Small changes in the discount rate or growth move the result a lot, as the table above shows. Change them yourself in the calculator.
Adjust the assumptions
Move the sliders for growth, long-run growth and discount rate, or switch to average free cash flow, and see the value per share change.
Adjust the assumptions